|
|
|
|
USDA, Agricultural Research Service, Western Human Nutrition Research Center, University of California, Davis, CA 95616
* To whom correspondence should be addressed. E-mail: szunino{at}whnrc.usda.gov.
Type I juvenile diabetes mellitus is characterized by the infiltration of activated T lymphocytes and monocytes into the islets of Langerhans of the pancreas, resulting in inflammation and progressive destruction of the insulin-producing ß cells. We hypothesized that feeding nonobese diabetic (NOD) mice diets rich in polyphenols or vitamin A, both known modulators of immune function, would decrease the autoimmune inflammatory process associated with type I diabetes. NOD mice were fed a control diet (C) and diets containing either 1% freeze-dried grape powder (GP) or 250 IU vitamin A/g (VA; 0.262 µmol retinyl acetate/g) of food. Mice were considered diabetic and killed when blood glucose reached 13.9 mmol/L or greater. By
7 mo of age, 71% of C mice progressed to diabetes. Incidence of diabetes was reduced to 33% (P < 0.05) and 25% (P < 0.05) in mice receiving 1% dietary grape powder and VA, respectively. Splenocytes from mice receiving both GP and VA had lower TNF-
production after LPS stimulation than C mice (P < 0.05). Histological analysis of pancreatic tissue showed a significant reduction in the severity of insulitis in the mice receiving GP and VA compared with C mice. These data suggest that diets rich in polyphenols or vitamin A have protective effects against autoimmune inflammatory attack of the islet ß cells and have the potential to reduce the onset and pathogenesis of autoimmune diabetes.
This article has been cited by other articles:
![]() |
C. Wasserfall and M. A. Atkinson Taking a Daily Vitamin to Prevent Type 1 Diabetes? Diabetes, January 1, 2009; 58(1): 24 - 25. [Full Text] [PDF] |
||||
![]() |
Y.-H. Van, W.-H. Lee, S. Ortiz, M.-H. Lee, H.-J. Qin, and C.-P. Liu All-trans Retinoic Acid Inhibits Type 1 Diabetes by T Regulatory (Treg)-Dependent Suppression of Interferon-{gamma}-Producing T-cells Without Affecting Th17 Cells Diabetes, January 1, 2009; 58(1): 146 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xiao, H. Jin, T. Korn, S. M. Liu, M. Oukka, B. Lim, and V. K. Kuchroo Retinoic Acid Increases Foxp3+ Regulatory T Cells and Inhibits Development of Th17 Cells by Enhancing TGF-{beta}-Driven Smad3 Signaling and Inhibiting IL-6 and IL-23 Receptor Expression J. Immunol., August 15, 2008; 181(4): 2277 - 2284. [Abstract] [Full Text] [PDF] |
||||